Oxford Biodynamics (OBD) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
No historical short positions

Oxford Biodynamics' international store for clinical smart tests and research kits based on pioneering EpiSwitch® 3D genomic technology.

OBD was spun out of Oxford University in 2007 to commercialize blood tests based on 3D Genomics research. OBD's tests are designed to help people make informed health decisions and reduce healthcare costs.

OBD share price launched at 162p in 2016.

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100

Latest directors dealings